2024-11-22 11:56:51
Brii Biosciences Announces Positive Data Demonstrating its Long-Acting COVID-19 Neutralizing Antibody Therapy, Amubarvimab/Romlusevimab Combination, Retains Neutralizing Activity Against Live Omicron Virus BA.4/5 and BA.2.12.1 Subvariants
Corporate/ 2023-07-24
Brii Biosciences Announces Positive Data...

Independent lab results demonstrate that the combination therapy retains neutralizing activity against currently dominant COVID-19 strains,a...

Vaccines alone aren't enough to combat AMR, claims new WHO report
Health/ 2023-07-22
Vaccines alone aren't enough to com...

The Global Hygiene Council (GHC) calls for the use of hygiene practices,such as handwashing,alongside vaccinations to prevent the spread of ...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release